CD200 and melanoma: Petermann et al. demonstrated that CD200 expression in melanoma cell lines was associated with an inability of DCs to activate primary T cells (Figure 2D), as evidenced by significantly decreased IL-2 and IFN-γ production in mixed lymphocyte reactions (MLR).